Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial. (nature.com)

Authors: Zhao P … Zhang XH Journal: Nature Communications Published: 2026-07-25 DOI: https://doi.org/10.1038/s41467-026-75344-7